Sagaert X et al . VH gene mutation status in gastrointestinal MALT lymphomas ginal zone B-cell lymphomas may arise from different subsets <strong>of</strong> marginal zone B lymphocytes. Blood 2001; 98: 781-786 30 Coupland SE, Foss HD, Anagnostopoulos I, Hummel M, Stein H. Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas <strong>of</strong> the ocular adnexa. Invest Ophthalmol Vis Sci 1999; 40: 555-562 31 Craig VJ, Arnold I, Gerke C, Huynh MQ, Wündisch T, Neubauer A, Renner C, Falkow S, Müller A. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood 2010; 115: 581-591 32 Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 1996; 10: 1190-1197 33 Du MQ, Xu CF, Diss TC, Peng HZ, Wotherspoon AC, Isaacson PG, Pan LX. Intestinal dissemination <strong>of</strong> gastric mucosa-associated lymphoid tissue lymphoma. Blood 1996; 88: 4445-4451 34 Hara Y, Nakamura N, Kuze T, Hashimoto Y, Sasaki Y, Shirakawa A, Furuta M, Yago K, Kato K, Abe M. Immunoglobulin heavy chain gene analysis <strong>of</strong> ocular adnexal extranodal marginal zone B-cell lymphoma. Invest Ophthalmol Vis Sci 2001; 42: 2450-2457 35 Kurosu K, Yumoto N, Furukawa M, Kuriyama T, Mikata A. Low-grade pulmonary mucosa-associated lymphoid tissue lymphoma with or without intraclonal variation. Am J Respir Crit Care Med 1998; 158: 1613-1619 36 Marasca R, Vaccari P, Luppi M, Zucchini P, Castelli I, Barozzi P, Cuoghi A, Torelli G. Immunoglobulin gene mutations and frequent use <strong>of</strong> VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol 2001; 159: 253-261 37 Miranda RN, Cousar JB, Hammer RD, Collins RD, Vnencak- Jones CL. Somatic mutation analysis <strong>of</strong> IgH variable regions reveals that tumor cells <strong>of</strong> most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed <strong>of</strong> memory B lymphocytes. Hum Pathol 1999; 30: 306-312 38 Qin Y, Greiner A, Trunk MJ, Schmausser B, Ott MM, Müller- Hermelink HK. Somatic hypermutation in low-grade mucosaassociated lymphoid tissue-type B-cell lymphoma. Blood 1995; 86: 3528-3534 39 Tierens A, Delabie J, Pittaluga S, Driessen A, DeWolf-Peeters C. Mutation analysis <strong>of</strong> the rearranged immunoglobulin heavy chain genes <strong>of</strong> marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. Blood 1998; 91: 2381-2386 40 Traverse-Glehen A, Davi F, Ben Simon E, Callet-Bauchu E, Felman P, Baseggio L, Gazzo S, Thieblemont C, Charlot C, Coiffier B, Berger F, Salles G. Analysis <strong>of</strong> VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence <strong>of</strong> clonal selection. Haematologica 2005; 90: 470-478 41 Klein U, Rajewsky K, Küppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998; 188: 1679-1689 42 Tangye SG, Liu YJ, Aversa G, Phillips JH, de Vries JE. Identification <strong>of</strong> functional human splenic memory B cells by expression <strong>of</strong> CD148 and CD27. J Exp Med 1998; 188: 1691-1703 43 Maurer D, Holter W, Majdic O, Fischer GF, Knapp W. CD27 expression by a distinct subpopulation <strong>of</strong> human B lymphocytes. Eur J Immunol 1990; 20: 2679-2684 44 Maurer D, Fischer GF, Fae I, Majdic O, Stuhlmeier K, Von Jeney N, Holter W, Knapp W. IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol 1992; 148: 3700-3705 45 Agematsu K, Nagumo H, Yang FC, Nakazawa T, Fukushima K, Ito S, Sugita K, Mori T, Kobata T, Morimoto C, Komiyama A. B cell subpopulations separated by CD27 and crucial collabo- ration <strong>of</strong> CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol 1997; 27: 2073-2079 46 Agematsu K, Nagumo H, Oguchi Y, Nakazawa T, Fukushima K, Yasui K, Ito S, Kobata T, Morimoto C, Komiyama A. Generation <strong>of</strong> plasma cells from peripheral blood memory B cells: synergistic effect <strong>of</strong> interleukin-10 and CD27/CD70 interaction. Blood 1998; 91: 173-180 47 Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today 1995; 16: 237-242 48 Chang B, Casali P. The CDR1 sequences <strong>of</strong> a major proportion <strong>of</strong> human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 1994; 15: 367-373 49 Kepler TB, Perelson AS. Cyclic re-entry <strong>of</strong> germinal center B cells and the efficiency <strong>of</strong> affinity maturation. Immunol Today 1993; 14: 412-415 50 Stein K, Hummel M, Korbjuhn P, Foss HD, Anagnostopoulos I, Marafioti T, Stein H. Monocytoid B cells are distinct from splenic marginal zone cells and commonly derive from unmutated naive B cells and less frequently from postgerminal center B cells by polyclonal transformation. Blood 1999; 94: 2800-2808 51 Tierens A, Delabie J, Michiels L, Vandenberghe P, De Wolf- Peeters C. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 1999; 93: 226-234 52 Dunn-Walters DK, Isaacson PG, Spencer J. Analysis <strong>of</strong> mutations in immunoglobulin heavy chain variable region genes <strong>of</strong> microdissected marginal zone (MGZ) B cells suggests that the MGZ <strong>of</strong> human spleen is a reservoir <strong>of</strong> memory B cells. J Exp Med 1995; 182: 559-566 53 Dunn-Walters DK, Isaacson PG, Spencer J. Sequence analysis <strong>of</strong> rearranged IgVH genes from microdissected human Peyer's patch marginal zone B cells. Immunology 1996; 88: 618-624 54 Morse HC 3rd, Kearney JF, Isaacson PG, Carroll M, Fredrickson TN, Jaffe ES. Cells <strong>of</strong> the marginal zone--origins, function and neoplasia. Leuk Res 2001; 25: 169-178 55 Hussell T, Isaacson PG, Crabtree JE, Dogan A, Spencer J. Immunoglobulin specificity <strong>of</strong> low grade B cell gastrointestinal lymphoma <strong>of</strong> mucosa-associated lymphoid tissue (MALT) type. Am J Pathol 1993; 142: 285-292 56 Greiner A, Marx A, Heesemann J, Leebmann J, Schmausser B, Müller-Hermelink HK. Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest 1994; 70: 572-578 57 Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini A, Cesari P, Graffeo M, Vaira D, Franzin G. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis <strong>of</strong> body atrophic gastritis. <strong>Gastroenterology</strong> 1996; 111: 655-665 58 Xiao Y, Hendriks J, Langerak P, Jacobs H, Borst J. CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. J Immunol 2004; 172: 7432-7441 59 Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-1847 60 Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form <strong>of</strong> chronic lymphocytic leukemia. Blood 1999; 94: 1848-1854 61 Kienle D, Kröber A, Katzenberger T, Ott G, Leupolt E, Barth TF, Möller P, Benner A, Habermann A, Müller-Hermelink HK, Bentz M, Lichter P, Dōhner H, Stilgenbauer S. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood 2003; 102: 3003-3009 62 Du MQ, Isaccson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002; 3: 97-104 S- Editor Wang JL L- Editor Hughes D E- Editor Ma WH WJGO|www.wjgnet.com 32 February 15, 2011|Volume 3|Issue 2|
Online Submissions: http://www.wjgnet.com/1948-5204<strong>of</strong>fice wjgo@wjgnet.com www.wjgnet.com <strong>World</strong> J Gastrointest Oncol 2011 February 15; 3(2): I ISSN 1948-5204 (online) © 2011 Baishideng. All rights reserved. ACKNOWLEDGMENTS Acknowledgments to reviewers <strong>of</strong> <strong>World</strong> <strong>Journal</strong> <strong>of</strong> Gastrointestinal Oncology Many reviewers have contributed their expertise and time to the peer review, a critical process to ensure the quality <strong>of</strong> <strong>World</strong> <strong>Journal</strong> <strong>of</strong> Gastrointestinal Oncology. The editors and authors <strong>of</strong> the articles submitted to the journal are grateful to the following reviewers for evaluating the articles (including those published in this issue and those rejected for this issue) during the last editing time period. Shih-Hwa Chiou, MD, PhD, Associate Pr<strong>of</strong>essor, Department <strong>of</strong> Medical Research and Education, Taipei Veterans General Hospital, No. 201, Sec. 2, ShihPai Road, Taipei 11217, Taiwan, China Stephen John Clarke, Pr<strong>of</strong>essor, Department <strong>of</strong> Medicine, Concord Repatriation General Hospital, Concord, NSW 2139, Australia Mitsuhiro Fujishiro, MD, PhD, Department <strong>of</strong> <strong>Gastroenterology</strong>/Internal Medicine, Graduate School <strong>of</strong> Medicine, University <strong>of</strong> Tokyo, 731, Hongo, Bunkyoku, Tokyo 1138655, Japan Michael Gnant, MD, Department <strong>of</strong> Surgery, Medical University <strong>of</strong> Vienna, Waehringer Guertel 1820, Vienna A1090, Austria Osamu Handa, MD, PhD, Assistant Pr<strong>of</strong>essor, Department <strong>of</strong> Molecular <strong>Gastroenterology</strong> and Hepatology, Kyoto Prefectural University <strong>of</strong> Medicine, 465 Kajiicho, Kawaramachi Hirokoji, Kamigyo, Kyoto 6028566, Japan Eiso Hiyama, MD, PhD, Department <strong>of</strong> General Medicine, Hiroshima University Medical Hospital, Hiroshima University, 123 Kasumi, Minamiku, Hiroshima, 7348551, Japan Simon Ng, Pr<strong>of</strong>essor, Division <strong>of</strong> Colorectal Surgery, Department <strong>of</strong> Surgery, University <strong>of</strong> Hong Kong; Department <strong>of</strong> Surgery, Prince <strong>of</strong> Wales Hospital, Shatin, Room 64045, 4/F, Clinical Sciences Building, Hong Kong, China Sai Yi Pan, MD, Centre for Chronic Diseases Prevention and Control, Public Health Agency <strong>of</strong> Canada, 785 Carling Ave, 7th Floor, A.L. 6807B, Ottawa, Ontario, K1A 0K9, Canada Lydia Inés Puricelli, PhD, Pr<strong>of</strong>essor, Head <strong>of</strong> Molecular Experimental Oncology Section, Research Area, Institute <strong>of</strong> Oncology, University <strong>of</strong> Buenos Aires, Buenos Aires 1426, Argentina Juan Carlos Roa, Associate Pr<strong>of</strong>essor, Director, Molecular pathology laboratory, Director <strong>of</strong> Postgrade and Research, School <strong>of</strong> Medicine, Universidad de La Frontera, Temuco 4781176, Chile David W Townsend, Pr<strong>of</strong>essor, Department <strong>of</strong> Medicine, University <strong>of</strong> Tennessee Medical Center, 1924 Alcoa Highway, Knoxville, TN 37920, United States Jan B Vermorken, MD, PhD, Pr<strong>of</strong>essor, Department <strong>of</strong> Medical Oncology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium Xiao-Chun Xu, Associate Pr<strong>of</strong>essor, Department <strong>of</strong> Clinical Cancer Prevention, The University <strong>of</strong> Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1360, Houston, TX 77030, United States Zuo-Feng Zhang, PhD, Department <strong>of</strong> Epidemiology, UCLA School <strong>of</strong> Public Health, 71225 CHS, Box 951772, 650 Charles E. Young Drive, South, Los Angeles, CA 900951772, United States WJGO|www.wjgnet.com I February 15, 2011|Volume 3|Issue 2|
Change language